Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5054)
All Articles published online
|
Publishing Process of This Article
|
Aug 6, 2013 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Slangen RM, van den Eertwegh AJ, van Bodegraven AA, de Boer NK. Diarrhoea in a patient with metastatic melanoma: Ipilimumab ileocolitis treated with infliximab. World J Gastrointest Pharmacol Ther 2013; 4(3): 80-82 [PMID: 23919220 DOI: 10.4292/wjgpt.v4.i3.80] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v4/i3/80.htm |
| Number | Citing Articles |
| 1 |
Magnus Pedersen, Rikke Andersen, Peter Nørgaard, Søren Jacobsen, Peter Thielsen, Per thor Straten, Inge Marie Svane. Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease. Cancer Immunology, Immunotherapy 2014; 63(12): 1341 doi: 10.1007/s00262-014-1607-y
|
| 2 |
Erika Rijavec, Carlo Genova, Giulia Barletta, Giovanni Burrafato, Federica Biello, Maria Giovanna Dal Bello, Simona Coco, Anna Truini, Angela Alama, Francesco Boccardo, Francesco Grossi. Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy. Expert Opinion on Biological Therapy 2014; 14(7): 1007 doi: 10.1517/14712598.2014.907786
|
| 3 |
Jagpal S. Klair, Mohit Girotra, Laura F. Hutchins, Kari D. Caradine, Farshad Aduli, Mauricio Garcia-Saenz-de-Sicilia. Ipilimumab-Induced Gastrointestinal Toxicities: A Management Algorithm. Digestive Diseases and Sciences 2016; 61(7): 2132 doi: 10.1007/s10620-016-4042-4
|
| 4 |
Tasha Hughes, Matthew Klairmont, William H. Sharfman, Howard L. Kaufman. Interleukin-2, Ipilimumab, and Anti-PD-1: clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma. Cancer Biology & Therapy 2021; 22(10-12): 513 doi: 10.1080/15384047.2015.1095401
|
| 5 |
Dmitry A. Sychev, Olga D. Ostroumova, Liliya E. Ziganshina, Anastasiya V. Filippova. Drug-induced diarrhea associated with antineoplastic drugs. HERALD of North-Western State Medical University named after I.I. Mechnikov 2021; 13(3): 5 doi: 10.17816/mechnikov84052
|
| 6 |
Vito Annese, Laurent Beaugerie, Laurence Egan, Livia Biancone, Claus Bolling, Christian Brandts, Daan Dierickx, Reinhard Dummer, Gionata Fiorino, Jean Marc Gornet, Peter Higgins, Konstantinos H Katsanos, Loes Nissen, Gianluca Pellino, Gerhard Rogler, Franco Scaldaferri, Edyta Szymanska, Rami Eliakim. European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies. Journal of Crohn's and Colitis 2015; 9(11): 945 doi: 10.1093/ecco-jcc/jjv141
|
| 7 |
Pol Specenier. Ipilimumab in melanoma. Expert Review of Anticancer Therapy 2016; 16(8): 811 doi: 10.1080/14737140.2016.1211936
|
| 8 |
Omar Abdel-Rahman, Hesham ElHalawani, Mona Fouad. Risk of Gastrointestinal Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-Analysis. Immunotherapy 2015; 7(11): 1213 doi: 10.2217/imt.15.87
|
| 9 |
Robert Cheng, Adam Cooper, James Kench, Geoff Watson, William Bye, Catriona McNeil, Nicholas Shackel. Ipilimumab‐induced toxicities and the gastroenterologist. Journal of Gastroenterology and Hepatology 2015; 30(4): 657 doi: 10.1111/jgh.12888
|
| 10 |
Steven P. Merrill, Paul Reynolds, Avash Kalra, Jason Biehl, R. William Vandivier, Scott W. Mueller. Early Administration of Infliximab for Severe Ipilimumab-Related Diarrhea in a Critically Ill Patient. Annals of Pharmacotherapy 2014; 48(6): 806 doi: 10.1177/1060028014528152
|
| 11 |
Andrew P. Wright, Marc S. Piper, Shrinivas Bishu, Ryan W. Stidham. Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor‐induced colitis. Alimentary Pharmacology & Therapeutics 2019; 49(12): 1474 doi: 10.1111/apt.15263
|
| 12 |
Yasuo Hamamoto, Natalya Shin, Tomohiro Hoshino, Takanori Kanai. Management of Challenging Immune-Related Gastrointestinal Adverse Events Associated with Immune Checkpoint Inhibitors. Future Oncology 2018; 14(30): 3187 doi: 10.2217/fon-2018-0509
|
| 13 |
Eric A.R. Gielisse, Nanne K.H. de Boer. Ipilimumab in a patient with known Crohn's disease: To give or not to give?. Journal of Crohn's and Colitis 2014; 8(12): 1742 doi: 10.1016/j.crohns.2014.08.002
|
| 14 |
J. Daniel Herlihy, Stephen Beasley, Andrew Simmelink, Vinaya Maddukuri, Asim Amin, Michal Kamionek, Carl Jacobs, Krista Bossi, Martin Scobey. Flexible Sigmoidoscopy Rather than Colonoscopy Is Adequate for the Diagnosis of Ipilimumab-Associated Colitis. Southern Medical Journal 2019; 112(3): 154 doi: 10.14423/SMJ.0000000000000944
|